Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. covers the month of October 2013. The report serves as a Material Fact Notice regarding regulatory approvals received from the Brazilian Securities Commission (CVM).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notice and does not contain financial performance data.
Material Changes
On October 30, 2013, the CVM granted Ambev S.A. registration as a publicly-held company in the "A" category pursuant to CVM Ruling No. 480/2009. This regulatory change enables the company to list its securities in specific market segments.
Outlook and Management Commentary
Management expects the Company's shares and American Depositary Receipts (ADRs) to begin trading around mid-November 2013. The shares are expected to trade in the traditional listing segment of BM&FBOVESPA S.A., while the ADRs are expected to trade on the New York Stock Exchange. The company stated it will inform the market of any further steps regarding this matter.
Investor Verification Checklist
- Confirm the exact trading start date for shares on BM&FBOVESPA and ADRs on the NYSE.
- Verify the specific listing segment requirements for the "A" category under CVM Ruling No. 480/2009.
- Monitor subsequent announcements for any delays or changes to the mid-November 2013 trading timeline.